drug · protein

DESMODA

updated 2mo ago

by $ETON Eton Pharmaceuticals, Inc.🔗 ChEMBL

community read0 votes

Protein drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 3 investigational indications.

targets

Vasopressin receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

DESMODA

trade names

Concentraid, Ddavp, Ddavp (needs no refrigeration), Desmomelt, Desmopressin acetate, Desmopressin acetate (needs no refrigeration)

generic

DESMOPRESSIN ACETATE

MOA

12.1 Mechanism of Action Desmopressin acetate’s primary pharmacodynamic action involves its binding to vasopressin 2 (V2) receptors. V2 receptors are primarily located in the distal convoluted tubule and collecting ducts of the nephron in the kidneys. These receptors play a crucial role in regulating water reabsorption and urine concentration. By influencing the permeability of the renal tubules, V2 receptors help maintain the body’s water balance and overall homeostasis.

indication

1 INDICATIONS AND USAGE DESMODA is indicated for the management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. Limitations of Use • DESMODA is not indicated for the treatment of nephrogenic diabetes insipidus. DESMODA is a vasopressin analog indicated for the management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. Limitations of Use • DESMODA is not indicated for the treatment of nephrogenic diabetes insipidus.

DESMODA

targets

all catalysts(0)

News(0)

Report a data issue

comments(0)

🐶 often sniffed alongside